|
ABOUT COMPANY
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North America, Europe, and internationally. The company is headquartered in Petach Tikva, Israel.
|
EARNINGS
Gross Profit (TTM): 7726000000
Market Capitalization: 9660300000
Operating Margin (TTM): 0.178
PE Ratio: 12.14
PEG Ratio: 0.736
Profit Margin: 0.0447
Revenue Per Share (TTM): 14.75
Revenue (TTM): 16231000000
Quarterly Earnings Growth YOY: 0.469
Quarterly Revenue Growth YOY: -0.023
Trailing PE: 12.14
|
DIVIDENDS
Diluted EPS (TTM): 0.66
Dividend Date: 2017-12-12
Dividend Per Share: 0
Dividend Yield: 0%
EBITDA: 4296000000
ExDividend Date: 2017-11-27
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|